Invajo - Events tool Create event for free
VGR Campus Nya Varvet (conference room Havsörnen)
September 6 - 7, 2018
09:00 - 13:00


The meeting will start at 09:00 on 6 September, and end at 13:00 on 7 September.

It is a great pleasure for us to announce some of the confirmed speakers who will share with you strong innovation projects arising from excellent Swedish neuroscience research and addressing common neurological conditions in desperate need for effective therapy. In addition to interesting presentations, this event will provide a unique opportunity to meet and network.

Preliminary Program:

Day 1 – September 6th

09.00 Arrival at Nya Varvet Göteborg & coffee
09.30 Introduction

09.40-10.50 AD panel – academia, industry, health care
Chair: Gunilla Osswald, CEO at BioArtic AB
Medical need and innovation landscape
·       Kaj Blennow, GU (20 min): Swedish research on CSF biomarkers - from early developments to the basis for the biological definition of Alzheimer’s Disease
Short presentation of innovation projects
·       Per Wester- Alzinova (15 min): Active immunotherapy - A new innovation in Alzheimer's treatment
·       Gunilla Osswald- BioArctic  (15 min): Disease modification treatment for Alzheimer´s disease – in sight!
        -Positive Phase 2b results of BAN2401 in early AD

·       Leslie Pendrill- RISE (15 min): Improved analysis of correlation between cognitive ability and AD biomarkers

10.50-11.20 Coffee

11.20-12.10 AD panel continued
·       Short presentation of innovation projects
·       Petronella Kettunen, GU (10 min): The zebrafish as an emerging model for drug discovery in CNS disease
·       Samuel Svensson, CBD Solutions (10 min): Development of selective TAU PET tracers for neuroimaging in 4R-tauopathies
Discussion panel- Innovations for new approaches in AD

12.10-13.30 Lunch

13.30-16.00 Stroke panel – academia, industry, health care
Chairs: Wieloch, Pekna, Pekny
·       Medical needs and innovation projects:
·       Tadeusz Wieloch, LU and Sinntaxis AB: mGluR5 as novel pharmacological target for stroke recovery
·       Marcela Pekna, GU: The complement system - experimental therapy to promote stroke recovery
·       Milos Pekny, GU: Astrocytes, a novel therapeutic target in neurodegeneration
·       Karsten Ruscher, LU: Receptor mediated plasticity by triiodothyronine in stroke
·       Mikael Persson, Chalmers: Portable diagnostics for ambulances

Discussion panel – Innovations for new approaches in stroke
(Wieloch, LU & Sinntaxis; Hicks, AstraZeneca; Pekny, GU; Pekna, GU)

16.00-16.20 Coffee


Åsa Wallin, Swelife: Innovation and collaboration in Life Science – from ideas to societal benefits
Mikael von und zu Fraunberg, Neurocenter Finland: Neurocenter Finland - promoting neuroscience and innovation
Erik Portelius, Alzheimer Sverige


17.30 Get-together

18.00 Dinner

Day 2  - September 7th

09.00-09.50 PD panel – academia, industry, health care
Unmet medical needs and ongoing clinical trials
·       Per Svenningsson, KI (20 min)  

Short presentation of innovation projects
·       Christer Möller, BioArctic (15 min): Disease modification treatment for Parkinson´s disease – in progress!
·       Nicholas Waters, IRLAB (15 min): IRL790 and IRL752 – two phase II programs addressing medical needs in PD

09.50-10.20 Coffee

10.20-11.20 PD panel continued
Short presentation of innovation projects
·       Angela Cenci Nilsson, LU (10 min): An experimental platform to evaluate potential disease-modifying treatments for Parkinson’s disease
·       Francesco Bez, Redoxis (10 min): Flow cytometric microglia detection in PD models

·       Jeanette Hällgren Kotaleski, KTH & HBP (10 min): Multiscale modeling and simulations as tools to interpret efficacy data in PD and other CNS disorders
Discussion panel – innovations for better treatments in PD

11:20-11.40 Break


Panel discussion: How to ensure that innovative ideas and projects are supported by adequate resources and expertise to reach the market and make impact on the society

Chair: Tadeusz Wieloch

Miia Kivipelto:
summarises the meeting and sets the stage
Mikael von und zu Fraunberg,
Finland Neuroscience Center
Magnus Björsne,
AstraZeneca BioVentureHub
Mats Ferm, KI Innovation AB


12.40-13.00 BrainGain Tass and the Road Ahead

13.00 End of meeting
Program Committee: Kina Höglund (GU), Peder Svensson (IRL), Milos Pekny (GU), Marcela Pekna (GU), Tadeusz Wieloch (LU)